Acasti Pharma Inc. (ACST)
3.37
0.13 (4.01%)
At close: Oct 25, 2024, 8:00 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 |
| Revenue | n/a | n/a | n/a | 196.00K | n/a | n/a | n/a | n/a | 27.79K | 216.29K | 450.16K | 707.39K | 127.11K | 29.04K | n/a |
| Cost of Revenue | 11.00K | 52.16M | 15.59M | 76.00K | 2.32M | 2.33M | n/a | n/a | 60.08K | 187.90K | 262.30K | 396.94K | 5.11K | n/a | n/a |
| Gross Profit | -11.00K | -52.16M | -15.59M | 120.00K | -2.32M | -2.33M | n/a | n/a | -32.29K | 28.39K | 187.86K | 310.45K | 122.01K | 29.04K | n/a |
| Operating Income | -11.31M | 15.72M | -15.59M | -10.72M | -24.44M | -33.71M | -15.25M | n/a | -7.09M | -9.91M | -9.71M | -6.82M | -6.55M | -2.44M | -1.54M |
| Interest Income | n/a | 246.00K | 77.00K | 107.00K | 336.00K | 355.75K | 55.75K | n/a | 54.23K | 69.54K | 28.99K | 46.15K | 43.39K | 12.04K | 19.03K |
| Pretax Income | -14.63M | -51.97M | -10.47M | -19.68M | -25.51M | -38.62M | -16.65M | n/a | -4.66M | -1.32M | -10.44M | -6.73M | -6.54M | n/a | -1.53M |
| Net Income | -12.85M | -42.43M | -9.82M | -19.68M | -25.76M | -43.86M | -16.94M | n/a | -4.66M | -1.32M | -10.44M | -6.73M | -6.54M | -2.43M | -1.51M |
| Selling & General & Admin | 6.67M | 8.21M | 9.78M | 6.66M | 8.46M | 4.24M | 3.12M | n/a | 1.61M | 4.72M | 6.03M | 4.19M | 3.51M | 857.75K | 408.59K |
| Research & Development | 4.63M | 9.97M | 5.56M | 4.17M | 15.97M | 28.73M | 12.13M | n/a | 5.45M | 5.21M | 3.86M | 2.94M | 3.16M | 1.46M | 1.12M |
| Other Expenses | n/a | 63.00K | n/a | 8.00K | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.00 | n/a | 146.87K | 11.40K |
| Operating Expenses | 11.30M | 18.25M | 15.34M | 10.84M | 24.44M | 32.97M | 15.25M | n/a | 7.06M | 9.93M | 9.89M | 7.13M | 6.67M | 2.47M | 1.54M |
| Interest Expense | 911.00K | 67.69M | 224.00K | 264.00K | 247.00K | 273.37K | 283.41K | n/a | 1.67K | 3.24K | 876.28 | 2.62K | 9.01K | 1.43K | 431.93 |
| Selling & Marketing Expenses | -252.00K | 136.00K | 518.00K | 1.14M | 2.67M | 660.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 11.31M | 18.25M | 15.34M | 10.91M | 24.44M | 32.97M | 15.25M | n/a | 7.12M | 10.12M | 10.16M | 7.53M | 6.68M | 2.47M | 1.54M |
| Income Tax | -1.78M | -9.54M | -648.00K | -127.00K | 247.00K | 5.24M | 291.15K | n/a | -2.38M | -8.52M | -246.40K | -41.82K | 22.40K | -12.04K | -30.43K |
| Shares Outstanding (Basic) | 9.53M | 7.44M | 6.14M | 2.47M | 1.76M | 6.79M | 2.19M | 2.19M | 222.08K | 221.20K | 175.77K | 151.57K | 140.06K | 106.88K | 45.02K |
| Shares Outstanding (Diluted) | 9.53M | 7.44M | 6.14M | 2.47M | 1.76M | 6.79M | 2.19M | 2.19M | 222.08K | 221.20K | 175.77K | 151.57K | 140.06K | 106.88K | 45.02K |
| EPS (Basic) | -1.35 | -5.71 | -1.6 | -7.96 | -14.62 | -6.46 | -7.75 | n/a | -20.99 | -5.98 | -59.37 | -44.42 | -46.68 | -22.71 | -33.5 |
| EPS (Diluted) | -1.35 | -5.71 | -1.6 | -7.96 | -14.62 | -6.46 | -7.75 | n/a | -20.99 | -5.98 | -59.37 | -44.42 | -46.68 | -22.71 | -33.5 |
| EBITDA | -11.30M | 15.85M | -19.99M | -9.95M | -21.83M | -30.99M | -14.01M | n/a | -5.27M | -7.97M | -9.09M | -6.12M | -5.84M | -2.42M | -1.53M |
| Depreciation & Amortization | 11.00K | 124.00K | 1.16M | 924.00K | 2.32M | 2.73M | 1.24M | 22.82K | 1.77M | 1.87M | 1.59M | 649.60K | 671.76K | 13.34K | 8.62K |